BII is real — and the FDA finally agrees
For decades, women reporting systemic symptoms after breast augmentation were dismissed. In 2021 the FDA formally acknowledged a link between breast implants (silicone and saline) and a cluster of systemic symptoms now widely recognized as Breast Implant Illness (BII).
That acknowledgment doesn't help much when your labs come back "normal" and your surgeon says the implants are inert. The mechanism isn't a simple allergic reaction — it's a multi-layer terrain problem of exactly the kind integrative medicine is built to map.
Why explant alone often isn't enough
Roughly 60–80% of women feel meaningfully better after a proper en bloc capsulectomy. The other 20–40% don't — and they're the ones who usually find us.
Three reasons explant stalls:
- Capsule fragments left behind — biofilm and immune triggers stay in the chest wall.
- Distributed toxic load — silicone, heavy metals, and biofilm byproducts have already migrated into lymph nodes, liver, fat stores, and connective tissue. Removing the source doesn't remove what's already systemic.
- Co-illness was already there — most BII patients also carry mold mycotoxin load, heavy metals, and chronic infections that the implants pushed past compensation. Read our full BII deep-dive.
The 6 layers we work through after explant
- Surgical completeness — confirm en bloc / total capsulectomy. If capsule was left, address it before chasing labs.
- Open drainage pathways — liver, kidney, lymph, bowel — before any binder or chelation.
- Targeted binders + lymphatic work — cholestyramine, charcoal, clay, chlorella; manual lymphatic drainage and sauna protocols.
- Mold + heavy metal clearance — almost universal in stalled BII cases. See our mold illness pillar.
- Mast cell + immune modulation — quercetin, DAO, low-dose naltrexone when indicated.
- Mitochondrial + hormonal + nervous-system rebuild — vagal tone, limbic retraining, HPA repair.
Testing we actually rely on
- Urine mycotoxin panel (RealTime Labs / Vibrant / GPL-MycoTOX) — mold is the most common co-driver.
- Hair tissue mineral analysis + provoked urine for heavy metals (silicone shells contain platinum and other metals).
- Organic Acids Test (OAT) — mitochondrial, fungal, detox markers.
- C4a, TGF-β1, MMP-9, MSH — Shoemaker inflammatory markers, frequently elevated in BII.
- DUTCH Complete — HPA axis, sex hormones (often crashed post-explant).
- Autonomic Response Testing (ART) / IRT — Dr. Nick's specialty (credentials) for sequencing the layers in the right order.
Why most post-explant recovery programs stall
Two errors dominate stalled BII recovery:
- Treating explant as the end. It's the start. The distributed toxic load needs months of targeted clearing after surgery, in the right sequence.
- Missing the mold co-illness. 70%+ of stalled BII cases have a parallel mycotoxin load. If you only treat the implant story, the mold story keeps the symptoms going.
The Foundation Membership covers most cases; complex multi-toxin presentations belong in the DNA Precision Program.
What healing actually looks like — months 1, 3, 6, 12
Month 1 (post-explant) — Drainage open, surgical completeness confirmed. Initial 20–30% symptom drop is common.
Month 3 — Binders + lymphatic work engaged. Brain fog clears. Mast cell symptoms space out.
Month 6 — Mold + metals clearing. Hormones often start to re-balance. Sleep deepens.
Month 12 — Most patients on maintenance. The "I forgot I was sick" window.